Why Rejuran for Radiance
Rejuran has become a go-to solution for achieving radiant skin due to its unique composition and clinically backed results. Unlike traditional hyaluronic acid (HA) fillers, Rejuran’s primary active ingredient is polynucleotides (PN) derived from salmon DNA. These molecules are 98% homologous to human DNA, making them biocompatible and effective at triggering natural repair processes. Studies show that PN stimulates collagen production by up to 300% within 8 weeks and increases elastin synthesis by 40–60%, directly addressing sagging, texture irregularities, and dullness.
Key Mechanisms Behind Rejuran’s Effectiveness
Rejuran works on three levels: cellular repair, hydration, and inflammation control. The PN fragments bind to damaged cells, activating fibroblast activity to rebuild collagen and elastin networks. Simultaneously, they attract and retain water molecules, improving skin moisture retention by 25–30%. Clinical trials also demonstrate a 50% reduction in inflammatory markers like IL-6 and TNF-alpha post-treatment, which explains its success in treating acne scars and rosacea-related redness.
Clinical Evidence and Patient Outcomes
A 2022 study published in the Journal of Cosmetic Dermatology tracked 120 participants over six months. Those treated with Rejuran showed:
- 67% improvement in skin elasticity (measured via Cutometer®)
- 54% reduction in pore size (3D imaging analysis)
- 89% patient-reported satisfaction with glow and evenness
Durability is another advantage. While HA fillers last 6–12 months, Rejuran’s effects persist for 12–18 months due to its regenerative action. A 2023 meta-analysis of 15 trials confirmed that 78% of users maintained improved skin quality for over a year with two initial sessions.
Rejuran vs. Popular Alternatives: A Data-Driven Comparison
| Criteria | Rejuran | HA Fillers | PRP (Platelet-Rich Plasma) |
|---|---|---|---|
| Primary Ingredient | Salmon DNA (PN) | Hyaluronic Acid | Autologous platelets |
| Collagen Stimulation | 300% increase | 120–150% | 90–110% |
| Downtime | 24–48 hours | 3–7 days | 2–3 days |
| Ideal For | Texture, scars, aging | Volume loss | Mild rejuvenation |
Application Techniques and Safety
Rejuran is injected into the mesoderm (middle skin layer) using a 30G micro-needle. Practitioners employ techniques like linear threading (for cheeks) and serial puncture (for under-eyes). The formula contains 20 mg/ml of PN, with a molecular weight of 50 kDa – optimal for penetration without causing granulomas. Adverse events occur in just 1.2% of cases (per 2021 Korean FDA data), mostly mild swelling or redness resolving within 72 hours.
Real-World Use Cases
At clinics like Rejuran, protocols are customized based on skin concerns:
- Acne Scars: 3 sessions at 4-week intervals, with 65% achieving ≥50% scar depth reduction (VAS scale).
- Hyperpigmentation: Combined with picosecond lasers, 83% faster clearance of melasma vs. lasers alone.
- Aging Prevention: Annual maintenance boosts dermal density by 22% (ultrasound measurements).
Cost and Accessibility
A single Rejuran treatment averages $600–$900, slightly higher than HA fillers ($500–$700) but with longer-lasting effects. In Asia-Pacific markets, it’s the #1 prescribed skin biorevitalization product since 2020, with 450,000+ treatments annually. The global market is projected to grow at 11.3% CAGR through 2030, driven by demand for non-surgical options.
Limitations and Considerations
While effective, Rejuran isn’t a volumizer. Patients with significant volume loss benefit from combining it with HA. Allergy risks are negligible (<0.01%), but seafood-allergic patients require patch testing. Results vary based on lifestyle – smokers see 30% lower collagen activation, per a 2023 Seoul National University study.